Indoleamine 2,3-Dioxygenase 1 (IDO1) in Kidney Transplantation: A Guardian against Rejection.

J Clin Med · 2023 · PMC10743959 · PMID 38137602

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Similarly, when examining pure antibody-mediated rejection (AMR), the difference in prevalence between IDO1(+) positive and IDO1(−) negative cases also failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.